Verastem (VSTM) Free Cash Flow (2011 - 2026)
Verastem (VSTM) recorded quarterly Free Cash Flow of -$52.1 million in Q1 2026, down 73.99% quarter-over-quarter from -$30.0 million in Q4 2025, and down 34.75% on a YoY basis from -$79.9 million in Q1 2025.
Verastem (VSTM) Free Cash Flow (2011 - 2026) Analysis & Trends
Verastem's Free Cash Flow history runs 16 years deep, the most recent figure standing at -$52.1 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 34.75% year-over-year to -$52.1 million; the TTM figure through Mar 2026 stood at -$150.9 million (down 31.09% YoY), while the FY2025 annual figure was -$137.5 million, down 31.21% from the prior year.
- Free Cash Flow was -$52.1 million for Q1 2026 at Verastem, down from -$30.0 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$12.7 million in Q2 2022 to a low of -$52.1 million in Q1 2026.
- Historically, Free Cash Flow has averaged -$26.2 million across 5 years, with a median of -$25.1 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Free Cash Flow sank 78.63% in 2023, then advanced 15.44% in 2024.
- A 5-year view of Free Cash Flow shows it stood at -$16.6 million in 2022, then tumbled by 78.63% to -$29.7 million in 2023, then rose by 15.44% to -$25.1 million in 2024, then declined by 19.34% to -$30.0 million in 2025, then sank by 73.99% to -$52.1 million in 2026.
- The last three Free Cash Flow figures came in at -$52.1 million (Q1 2026), -$30.0 million (Q4 2025), and -$36.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | -52.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.12 Mn |
| Mar 31, 2026 | -52.12 Mn |
| Dec 31, 2025 | -29.95 Mn |
| Dec 31, 2025 | -29.95 Mn |
| Sep 30, 2025 | -36.22 Mn |
| Sep 30, 2025 | -36.22 Mn |
| Jun 30, 2025 | -32.66 Mn |
| Jun 30, 2025 | -32.66 Mn |
| Mar 31, 2025 | -38.68 Mn |
| Mar 31, 2025 | -38.68 Mn |
| Dec 31, 2024 | -25.10 Mn |
| Dec 31, 2024 | -25.10 Mn |
| Sep 30, 2024 | -23.80 Mn |
| Sep 30, 2024 | -23.80 Mn |
| Jun 30, 2024 | -27.58 Mn |
| Jun 30, 2024 | -27.58 Mn |
| Mar 31, 2024 | -28.33 Mn |
| Mar 31, 2024 | -28.33 Mn |
| Dec 31, 2023 | -29.68 Mn |
| Dec 31, 2023 | -29.68 Mn |